Rapid preliminary purity evaluation of tumor biopsies using deep learning approach
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Tumor biopsy is one of the most widely used materials in cancer diagnoses and molecular studies, where the purity of the biopsies (i.e., proportion of cells that are cancerous) is crucial for both applications. However, conventional approaches for tumor biopsy purity evaluation require experienced pathologists and/or various materials/experiments therefore were time-consuming and error prone. Rapid, easy-to-perform and cost-effective methods are thus still of demand. Recent studies had demonstrated that molecular signatures were informative to this task. Previously, we had developed GeneCT, a deep learning-based cancerous status and tissue-of-origin classifier for pan-tumor/tissue biopsies. In the current work, we applied GeneCT on datasets collected from various groups, where the experimental protocols and cancer types differed from each other. We found that GeneCT showed high accuracies on most datasets; for samples with unexpected results, in-depth investigations suggested that they might suffer from imperfect purity. In silico mixture experiments further showed that GeneCT classification was highly indicative in predicting the purity of the tumor biopsies. Considering that transcriptome profiling is a common and inexpensive experiment in molecular cancer studies, our deep learning-based GeneCT could thus serve as a valuable tool for rapid, preliminary tumor biopsy purity assessment.
出版社接受日期05.06.2020
著者Fan Fei, Chen Dan, Zhao Yu, Wang Huating, Sun Hao, Sun Kun
期刊名稱Computational and Structural Biotechnology Journal
出版年份2020
卷號18
出版社Elsevier
頁次1746 - 1753
國際標準期刊號2001-0370
語言英式英語
關鍵詞RNA-seq, Gene expression, Machine learning, Cancer

上次更新時間 2021-28-02 於 23:38